Nicholson Donald William
Insider CIK 1814617 · GBIO Director · KYMR Director · IRON Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IRON Disc Medicine, Inc. | A Award deriv | 2026-06-18 | 2026-06-23 | 6,212 | — | $0 | 6,212 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 2,500 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 1,920 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 6,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 5,200 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | D To issuer deriv | 2026-02-09 | 2026-02-09 | 3,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | U Tender | 2026-02-09 | 2026-02-09 | 21,357 | — | $0 | 0 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2025-06-04 | 2025-06-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2024-06-06 | 2024-06-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2023-12-01 | 2023-12-05 | 100,000 | $1.44 | $144.0K | 213,576 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2023-06-09 | 2023-06-09 | 7,136 | — | $0 | 7,136 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2023-06-08 | 2023-06-12 | 25,000 | — | $0 | 25,000 | SEC↗ |
| IRON Disc Medicine, Inc. | A Award deriv | 2022-12-29 | 2023-01-03 | 7,000 | — | $0 | 7,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2022-06-09 | 2022-06-13 | 19,200 | — | $0 | 19,200 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-03-10 | 2022-03-11 | 8,126 | $4.71 | $38.3K | 113,576 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2022-03-09 | 2022-03-11 | 2,293 | $4.79 | $11.0K | 105,450 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,063 | — | $0 | 20,063 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2021-06-09 | 2021-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GBIO Generation Bio Co. | P Buy | 2021-01-11 | 2021-01-13 | 4,081 | $24.50 | $100.0K | 103,157 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-08-20 | 2020-08-21 | 40,127 | — | $0 | 40,127 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 100,000 | — | $0 | 0 | SEC↗ |
| GBIO Generation Bio Co. | C Conversion | 2020-06-16 | 2020-06-18 | 56,615 | — | $0 | 99,076 | SEC↗ |
| GBIO Generation Bio Co. | A Award deriv | 2020-06-11 | 2020-06-15 | 52,000 | — | $0 | 52,000 | SEC↗ |